Company: KAVL
Filing Date: 2025-06-16
Form Type: S-3
Source: 0001731122-25-000885
Chunk: 3

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-06-16
Form: S-3
Chunk 3
---
 prospectus is being delivered, the
names of such underwriters or agents and any applicable fees, commissions or discounts and over-allotment options will be set forth in
a prospectus supplement. The price to the public of such securities and the net proceeds that we expect to receive from such sale will
also be set forth in a prospectus supplement.

Pursuant to General Instruction I.B.6 of Form S-3,
in no event will we sell our securities in public primary offerings with a value exceeding more than one-third of our public float in
any 12-month period so long as our public float remains below $75.0 million. As of June 16, 2025, the aggregate market value of our outstanding
common stock held by non-affiliates, or public float, was approximately $3,573,807 based on 5,616,544 shares of our outstanding common
stock that were held by non-affiliates on such date and a price of $0.6363 per share, which was the price at which our common stock was
last sold on the Nasdaq Capital Market on May 20, 2025 calculated in accordance with General Instruction I.B.6 of Form S-3. We have not
offered any securities pursuant to General Instruction I.B.6 of Form S-3 during the twelve-month period that ends on and includes the
date hereof. Our common stock is listed on The Nasdaq Capital Market under the symbol “KAVL.”

On June 13, 2025, the last reported sale price of
our common stock was $0.55 per share. The applicable prospectus supplement will contain information, where applicable, as to any other
listing, if any, on The Nasdaq Capital Market or any securities market or other securities exchange of the securities covered by the prospectus
supplement. Prospective purchasers of our securities are urged to obtain current information as to the market prices of our securities,
where applicable.

Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks that we have described on page 12 of this prospectus under the caption “Risk Factors” and the risk factors in our most recent Annual Report on Form 10-K, which is incorporated by reference herein, as well as in any other recently filed quarterly or current reports. We may include specific risk factors in supplements to this prospectus under the caption “Risk Factors.” This prospectus